IP Library Granted Patent US 8,161,976
Granted Patent B2
US 8,161,976 · App. 11/906,457 · Granted Apr 24, 2012

Systems and methods for applying a selected treatment agent into contact with tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,161,976
App. No.
11/906,457
Granted
Apr 24, 2012
Kind
B2
Abstract

Systems and methods that treat disorders of the gastrointestinal tract by applying one or more treatment agents to tissue at or near the region where abnormal neurological symptoms or abnormal tissue conditions exist. The treatment agent is selected to either disrupt the abnormal nerve pathways and/or to alleviate the abnormal tissue conditions. The treatment agent can include at least one cytokine and/or at least one vanilloid compound to evoke a desired tissue response. The systems and methods can be used a primary treatment modality, or as a neoadjuvent or adjuvant treatment modality.

Claims (12)

1. A method of treating tissue within a body comprising

selecting at least one treatment agent comprising at least one of a vanilloid compound and a cytokine compound,

providing a source of the treatment agent,

deploying an endoscope to a targeted tissue region the endoscope having an interior lumen,

visualizing the targeted tissue region with the endoscope,

deploying through the interior lumen of the endoscope a catheter carrying on its distal end a tissue-piercing element adjacent to the targeted tissue region visualized by the endoscope,

coupling the catheter to the source of the treatment agent, and

applying through the tissue-piercing element the treatment agent into contact with the targeted tissue region visualized by the endoscope.

2. A method according to claim 1

wherein the applying includes injecting the treatment agent into subsurface tissue in the targeted tissue region.

3. A method according to claim 1

further including providing a guide wire to facilitate deployment of the endoscope and/or catheter.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2018
From: HORIZON CREDIT II LLC
To: MEDERI RF, LLC
Reel/Frame 046069/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 3, 2018
From: MEDERI THERAPEUTICS INC.
To: HORIZON CREDIT II LLC
Reel/Frame 046076/0317 →
SECURITY INTEREST Recorded Aug 3, 2015
From: MEDERI THERAPEUTICS INC.
To: HORIZON CREDIT II LLC
Reel/Frame 036252/0728 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 31, 2008
From: RESPIRATORY DIAGNOSTIC, INC.
To: MEDERI THERAPEUTICS, INC.
Reel/Frame 022047/0503 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 30, 2008
From: CURON MEDICAL, INC. BY JOHN T. KENDALL, TRUSTEE
To: RESPIRATORY DIAGNOSTIC, INC.
Reel/Frame 022034/0702 →